Editas Medicine, Inc. (EDIT) stock
EDITNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/309% above fair value
$1.82−0.05 (-2.41%)
Close on Nov 17, 2026Market cap $280.28MP/E –Yield –
Editas Medicine price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Editas Medicine's price to book ratio was 2.2× on Nov 11, 2026, against 16.7× a year earlier. Over the last 5 years it ranged from 0.6× to 76.8×, with a median of 1.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.2× | −12.0 |
| 2025 | Dec 31, 2025 | 14.2× | +13.6 |
| 2024 | Dec 31, 2024 | 0.6× | −1.7 |
| 2023 | Dec 29, 2023 | 2.3× | +0.8 |
| 2022 | Dec 30, 2022 | 1.5× | −1.6 |
| 2021 | Dec 31, 2021 | 3.1× | −6.8 |
| 2020 | Dec 31, 2020 | 9.9× | +2.7 |
| 2019 | Dec 31, 2019 | 7.2× | +2.4 |
| 2018 | Dec 31, 2018 | 4.8× | −2.4 |
| 2017 | Dec 29, 2017 | 7.2× | +3.8 |
| 2016 | Dec 30, 2016 | 3.4× | – |
See a number that looks wrong?